Table 2. Median values for significantly changed clones after first treatment with anti–CTLA-4 antibodies.

Clones with significantly different abundance separated by 1 month were identified as described in Fig. 2.

Number of clones with
increased abundance
Number of clones with
decreased abundance
Prostate297134
Melanoma21325
Combined23999
Untreated
controls
202